Impact of Minimal Residual Negativity using Next Generation Flow Cytometry on Outcomes in Light Chain Amyloidosis

We evaluated bone marrow minimal residual disease (MRD) negativity in 44 patients with light chain (AL) amyloidosis using next generation flow cytometry (sensitivity ≥ 1× 10(−5); median events analyzed: 8.7 million, range: 4.8 to 9.7 million). All patients underwent MRD testing in two years from sta...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Am J Hematol
Autores principales: Sidana, Surbhi, Muchtar, Eli, Sidiqi, M.Hasib, Jevremovic, Dragan, Dispenzieri, Angela, Gonsalves, Wilson, Buadi, Francis, Lacy, Martha Q., Hayman, Suzanne R., Kourelis, Taxiarchis, Kapoor, Prashant, Go, Ronald S., Warsame, Rahma, Leung, Nelson, Rajkumar, S.Vincent, Kyle, Robert A., Gertz, Morie A., Kumar, Shaji K.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2020
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC8019396/
https://ncbi.nlm.nih.gov/pubmed/32010993
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.25746
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares